Transaction · 0001104659-26-115642

Jeffs Roger

JEFFS ROGER, CEO, reported an open-market or private sale at Liquidia Corp involving 32744.000000 shares for an estimated $932549.12. Reported holdings after the transaction were 1125848.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO

LQDALiquidia Corp

Trade date: Oct 12, 2026
Filing date: Oct 13, 2026

View on SEC Insider profile

Estimated value-$932kShares × reported price

Shares traded32.7k$28.48 per share

Holdings after1.12MDirect

% of reported position traded2.83%This security and ownership context

How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,158,592 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

LQDA price since this filing

Daily closing prices, with the filing date and available return windows

LQDA · Daily closing priceLoading daily prices…

Filing dateReturn windows appear as prices become available.

Pre-filing1mo ago +148.9%1w ago +149.5%1d ago +2.1%

Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Sell
Identifier: 0001104659-26-115642
Transaction date: Oct 12, 2026
Shares: 32,744 sh
Estimated value: -$932k
Holdings after: 1,125,848 sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M

Cluster Selling Direct Ownership 10b5-1 Detected

Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated

direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.

Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No

Footnotes & amended

F1
Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
F2
On January 11, 2024, the Reporting Person was granted 221,338 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vest…
F3
Includes (i) 18,094 unvested restricted stock units ("RSUs") of the 289,500 RSUs granted to the Reporting Person on January 11, 2023, (ii) 69,168 unvested RSUs of the 221,338 RSUs granted to the Repor…
F4
On January 11, 2025, the Reporting Person was granted 229,327 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs vest…
F5
Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
F6
These shares were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.
F7
The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F8
The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Se…

Original filing · 0001104659-26-115642

Related transactions

0 other transactions

Same SEC filing

Recent company activity

0 recent txs

LQDA